Delivering high-quality endpoint data for late phase clinical studies
Book a demo of uMotif’s eCOA/ePRO platform to see how we power unparalleled levels of patient engagement that can transform the speed, accuracy and quality of data in your next late phase study
Our modern eCOA/ePRO engagement platform offers solutions for high-quality late phase clinical trials.
Late phase IIIb and IV clinical trials are crucial for gathering real-world evidence. uMotif’s eCOA/ePRO platform offers solutions for late phase clinical research by capturing symptoms, outcomes and eDiaries. Uniquely designed with patients, for patients, our platform helps reduce the burden of study participation to drive high levels of patient participation and compliance, in every study.
Available in any language and swiftly configured for global deployment for late phase clinical trials, uMotif’s validated platform supports the delivery of large-scale clinical trials across the globe. We achieve high rates of data capture and participant compliance and retention that often far exceeds our customers’ expectations.
High Compliance
Over 90% compliance in real-world studies
Faster Studies
Reducing study timelines by ⅓
Quality Data
Capturing GCP-compliant data, ready for submission
“We needed an easy-to-use solution, that can be used across multiple countries, to manage a high volume of data capture – uMotif’s platform provides the opportunity to engage our patients”
Professor Pratik Choudhary Project Lead, King’s College London
Trusted by leading companies
across the globe:
